ICD 10 CM F15.25 | Description & Clinical Information

ICD 10 F15.25 describes a condition in which an individual becomes dependent on a stimulant drug, requiring increasing amounts to achieve the same effect, experiences physical and/or mental symptoms upon abrupt withdrawal, and develops a thought disorder, such as delusions or hallucinations, that is induced by the stimulant drug and not represented by any other code.

Official Description Of F15.25

The ICD 10 CM book defines ICD 10 code F15.25 as:

When To Use F15.25

The diagnosis describes by ICD 10 CM F15.25 is stimulant dependence with psychotic disorder. This condition is often characterized by drug-seeking behaviors exhibited by individuals who have excessive stimulant use that results in functional changes in the brain. Many different kinds of stimulant drugs may be the cause of the condition, including amphetamines, methylphenidates, and other stimulants, which can be either legal or illegal.

Amphetamines are a type of stimulant drug that includes legal drugs such as Dexedrine and Adderall, which are commonly used to treat attention deficit hyperactive disorder (ADHD) and narcolepsy. Some amphetamines, such as methamphetamine, are illegal drugs. Other stimulants that may be abused also include methylphenidates, such as Ritalin and Concerta, which are used to treat ADHD, prescription methamphetamine called Desoxyn, and ephedrine, which is used to treat obesity.

Patients with stimulant dependence with psychotic disorder may experience a wide range of symptoms. These may include anxiety, fear, paranoia, hallucinations, delusions, and even aggressive or violent behavior when high doses are ingested. Providers may diagnose the condition by considering the patient’s medical history, signs and symptoms, a comprehensive inquiry into their personal and social behaviors, and physical examination.

Long-term methamphetamine use can be easily identified by the visible signs that it leaves on the body. Scattered skin sores, tooth decay and missing teeth, and extreme weight loss are common. Laboratory tests may be conducted on blood, urine, and other bodily fluids as well as hair to determine the levels of stimulant drugs present.

Treatment approaches for stimulant dependence with psychotic disorder may include cognitive behavioral therapy (CBT), psychotherapy, admission to a residential treatment center, and group therapy. Unfortunately, there are currently no drugs or medications available to prevent abuse or treat withdrawal symptoms effectively. However, some drugs like certain antipsychotic medications may help treat some specific symptoms of the disorder.

It is important to seek early intervention and diagnosis for individuals with stimulant dependence with psychotic disorder. The earlier the condition is identified, the better the chances of successful treatment and recovery. With ongoing support and management, many individuals are able to overcome their addiction and lead fulfilling lives free from the negative effects of stimulant drugs.